4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide

C155H141FN18O17S12 — CID 161339171

About 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide

4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide (PubChem CID 161339171) has the molecular formula C155H141FN18O17S12 and a molecular weight of 2931.74 g/mol. Its IUPAC name is 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide.

Molecular Properties

• Compound Name: 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide
• PubChem CID: 161339171
• Molecular Formula: C155H141FN18O17S12
• Molecular Weight: 2931.74 g/mol
• Exact Mass: 2928.74
• IUPAC Name: 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide
• SMILES: CNC(=O)c1ccc(CCC(=O)c2nc(-c3ncc(-c4ccccc4)s3)sc2C2CC2)cc1.C[C@@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2nc3c(s2)CCCC3)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccc(F)cc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.Cc1ccc(-c2cnc(-c3nc(C(=O)C[C@@H](C)c4ccc(C(=O)NO)cc4)c(C4CC4)s3)s2)cc1
• InChI: InChI=1S/C27H25N3O3S2.C26H22FN3O3S2.2C26H23N3O3S2.C26H23N3O2S2.C24H25N3O3S2/c1-15-3-5-18(6-4-15)22-14-28-26(34-22)27-29-23(24(35-27)19-9-10-19)21(31)13-16(2)17-7-11-20(12-8-17)25(32)30-33;1-14(15-2-6-18(7-3-15)24(32)30-33)12-20(31)22-23(17-4-5-17)35-26(29-22)25-28-13-21(34-25)16-8-10-19(27)11-9-16;2*1-15(16-7-11-19(12-8-16)24(31)29-32)13-20(30)22-23(18-9-10-18)34-26(28-22)25-27-14-21(33-25)17-5-3-2-4-6-17;1-27-24(31)19-10-7-16(8-11-19)9-14-20(30)22-23(18-12-13-18)33-26(29-22)25-28-15-21(32-25)17-5-3-2-4-6-17;1-13(14-6-10-16(11-7-14)22(29)27-30)12-18(28)20-21(15-8-9-15)32-24(26-20)23-25-17-4-2-3-5-19(17)31-23/h3-8,11-12,14,16,19,33H,9-10,13H2,1-2H3,(H,30,32);2-3,6-11,13-14,17,33H,4-5,12H2,1H3,(H,30,32);2*2-8,11-12,14-15,18,32H,9-10,13H2,1H3,(H,29,31);2-8,10-11,15,18H,9,12-14H2,1H3,(H,27,31);6-7,10-11,13,15,30H,2-5,8-9,12H2,1H3,(H,27,29)/t16-;14-;2*15-;;13-/m1110.1/s1
• InChIKey: VMKZXMONDQUJFA-BMHQJCFHSA-N
• XLogP: 37.18
• TPSA: 532.85 Ų
• H-Bond Donors: 11
• H-Bond Acceptors: 41
• Rotatable Bonds: 47
• Heavy Atoms: 203
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2931.74
LogP ≤ 5	37.18
H-Bond Donors ≤ 5	11
H-Bond Acceptors ≤ 10	41

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?

The IUPAC name of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide (CID 161339171) is 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide.

What is the SMILES notation for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?

The canonical SMILES for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide is CNC(=O)c1ccc(CCC(=O)c2nc(-c3ncc(-c4ccccc4)s3)sc2C2CC2)cc1.C[C@@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2nc3c(s2)CCCC3)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccc(F)cc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.C[C@H](CC(=O)c1nc(-c2ncc(-c3ccccc3)s2)sc1C1CC1)c1ccc(C(=O)NO)cc1.Cc1ccc(-c2cnc(-c3nc(C(=O)C[C@@H](C)c4ccc(C(=O)NO)cc4)c(C4CC4)s3)s2)cc1.

What is the InChIKey of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?

The InChIKey is VMKZXMONDQUJFA-BMHQJCFHSA-N. The full InChI is InChI=1S/C27H25N3O3S2.C26H22FN3O3S2.2C26H23N3O3S2.C26H23N3O2S2.C24H25N3O3S2/c1-15-3-5-18(6-4-15)22-14-28-26(34-22)27-29-23(24(35-27)19-9-10-19)21(31)13-16(2)17-7-11-20(12-8-17)25(32)30-33;1-14(15-2-6-18(7-3-15)24(32)30-33)12-20(31)22-23(17-4-5-17)35-26(29-22)25-28-13-21(34-25)16-8-10-19(27)11-9-16;2*1-15(16-7-11-19(12-8-16)24(31)29-32)13-20(30)22-23(18-9-10-18)34-26(28-22)25-27-14-21(33-25)17-5-3-2-4-6-17;1-27-24(31)19-10-7-16(8-11-19)9-14-20(30)22-23(18-12-13-18)33-26(29-22)25-28-15-21(32-25)17-5-3-2-4-6-17;1-13(14-6-10-16(11-7-14)22(29)27-30)12-18(28)20-21(15-8-9-15)32-24(26-20)23-25-17-4-2-3-5-19(17)31-23/h3-8,11-12,14,16,19,33H,9-10,13H2,1-2H3,(H,30,32);2-3,6-11,13-14,17,33H,4-5,12H2,1H3,(H,30,32);2*2-8,11-12,14-15,18,32H,9-10,13H2,1H3,(H,29,31);2-8,10-11,15,18H,9,12-14H2,1H3,(H,27,31);6-7,10-11,13,15,30H,2-5,8-9,12H2,1H3,(H,27,29)/t16-;14-;2*15-;;13-/m1110.1/s1.

What are the key properties of 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide?

4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide has a molecular weight of 2931.74 g/mol, XLogP of 37.18, 47 rotatable bonds, 11 hydrogen bond donors, and 41 hydrogen bond acceptors.

Where does this data come from?

All data for 4-[(2R)-4-[5-cyclopropyl-2-[5-(4-fluorophenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-[5-(4-methylphenyl)-1,3-thiazol-2-yl]-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2S)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[(2R)-4-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide;4-[3-[5-cyclopropyl-2-(5-phenyl-1,3-thiazol-2-yl)-1,3-thiazol-4-yl]-3-oxopropyl]-N-methylbenzamide;4-[(2R)-4-[5-cyclopropyl-2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1,3-thiazol-4-yl]-4-oxobutan-2-yl]-N-hydroxybenzamide is sourced from PubChem (CID 161339171), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).